Virtus Terranova U.S. Quality Momentum ETFJOET

The Virtus Terranova U.S. Quality Momentum ETF (JOET) kicked off July 2026 with a quiet reminder that ‘momentum’ in fund names often outlasts the actual momentum in portfolios. Data from Nasdaq shows the ETF traded X shares on July 25, 2026, with a last-price print of $X.XX, though its 52-week range remains undisclosed due to the fund’s relatively recent launch in 2025. The fund’s prospectus, filed with the SEC in Q1 2026, reiterates its focus on ‘high-quality U.S. companies with positive earnings momentum,’ but offers no specific metrics for how ‘quality’ is quantified beyond vague references to debt ratios and return on equity.

JOET’s top holdings, per its latest semi-annual report, include a mix of technology, healthcare, and consumer discretionary stocks, with no single position exceeding 5%-a nod to diversification that undercuts the ‘momentum’ hype. The fund’s expense ratio of 0.45% is detailed in FINRA’s Fund Analyzer, which notes it’s below the average for actively managed equity ETFs but higher than passive momentum strategies. Liquidity remains a question: the ETF’s average daily volume is just X shares, raising concerns about slippage during volatile periods.

The SEC filing also reveals JOET reserves the right to use derivatives for ‘capital preservation’ purposes, a clause that could introduce unlisted risks if market conditions deteriorate. Meanwhile, the fund’s tracking method-designed to replicate the ‘Terranova U.S. Quality Momentum Index’-has yet to be stress-tested in a prolonged bear market. With no dividend yield disclosed and a net asset value (NAV) that trails its underlying index by an undisclosed amount, JOET’s true ‘momentum’ may depend more on marketing than math.

What’s missing? Concrete performance data over a full market cycle, a clear explanation of how ‘proprietary’ screening differs from existing momentum factor models, and any disclosure of turnover rates that could impact long-term returns. Until then, JOET remains a bet on the persistence of the quality momentum narrative-and the hope that its fees don’t outpace its stated strategy.